In a statement for the record for the Senate Finance Committee hearing on protecting the reliability of the U.S. medical supply chain during the COVID-19 pandemic, Premier underscores how the existing private sector supply chain can be further enabled and augmented to prevent gaps in vital medical supplies to address future pandemics. To help strengthen and maintain the integrity of the supply chain during this and future pandemics, Premier recommends the creation of a centralized clearing house to vet gray market offers and test products to ensure integrity. Creating incentives for domestic manufacturing and revamping the Strategic National Stockpile through a public-private partnership is also urgently needed to ensure a steady supply of vital drugs and medical supplies are available for patient care. Finally, Premier calls for real-time syndromic surveillance to provide an upstream alternative to identifying cases before tests can detect them or patients are hospitalized. These are common-sense, market-based, holistic, and sustainable solutions that Congress can enact
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 250,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.